CONCORD BIO IPO
Concord Biotech's niche API play holds promise for growthET Intelligence Group: Ahmedabad-based Concord Biotech is a global supplier of bio-pharmaceutical APIs and formulations, serving more than ...
Concord Bio's Rs 1,551-crore IPO to open on Aug 4The issue, which will close on August 8, is entirely an offer-for-sale, where the existing shareholder Helix Investments Holdings will sell...
- Load More